GL
Geulah Livshits Chardan Capital Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
93
Avg Return
Past Year
Past Year
11%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $12 |
154%
upside
| 2 | +22% |
0
%
| 17 Oct ‘25 2 days ago |
|
|
|
Buy
Maintained
| $11 |
196%
upside
| 4 | -9% |
0
%
| 14 Oct ‘25 5 days ago |
|
|
|
Buy
Maintained
| $17 |
77%
upside
| 2 | +11% |
0
%
| 7 Oct ‘25 12 days ago |
|
|
|
Buy
Maintained
| $73 |
0%
downside
| 2 | +59% |
0
%
| 26 Sep ‘25 24 days ago |
|
|
|
Buy
Maintained
| $20 |
258%
upside
| 2 | +29% |
0
%
| 26 Sep ‘25 24 days ago |
|
|
|
Buy
Maintained
| $216 |
14%
upside
| 3 | +1.4% |
0
%
| 22 Aug ‘25 1 month ago |
|
|
|
Buy
Maintained
| $11 |
261%
upside
| 1 | +25% |
0
%
| 15 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $15 |
155%
upside
| 1 | +15% |
0
%
| 14 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $25 |
154%
upside
| 2 | +9% |
0
%
| 12 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $60 |
142%
upside
| 1 | +17% |
0
%
| 11 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $10 |
83%
upside
| 1 | +19% |
0
%
| 8 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $12 |
458%
upside
| 1 | +31% |
0
%
| 8 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $20 |
817%
upside
| 2 | -15% |
0
%
| 8 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $9 |
397%
upside
| 1 | +21% |
0
%
| 7 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $82 |
19%
upside
| 1 | +9.7% |
0
%
| 5 Aug ‘25 2 months ago |
|